1. All Products
  2. DORA - Oral drugs
  3. H 50mg / Z 150mg / R 75mg, disp. tab., blister
Public Pricelist

H 50mg / Z 150mg / R 75mg, disp. tab., blister

https://medicalguidelines.msf.org/en/node/422
https://unicat.msf.org/cat/product/64977
STD DORAHZRI5TD1

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM05
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ISONIAZID (H) / PYRAZINAMIDE (Z) / RIFAMPICIN (R)

Therapeutic Action

Fixed-dose combination (FDC) of three bactericide antituberculosis

Indications

Drug-Sensitive Tuberculosis (DS-TB)

Instructions for use

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

The quantity to be ordered is calculated per tablet, not per blister.

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity